Invention Application
- Patent Title: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF
-
Application No.: US16779011Application Date: 2020-01-31
-
Publication No.: US20200165349A1Publication Date: 2020-05-28
- Inventor: Isil ALTINTAS , David SATIJN , Rik RADEMAKER , Paul PARREN , Ugur SAHIN , Friederike GIESEKE , Alexander MUIK , Christian GRUNWITZ
- Applicant: GENMAB A/S , BIONTECH SE
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1e21c436 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4f677573
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention relates to novel binding agents and their use in medicine. In particular, the invention relates to binding agents such as bispecific antibodies binding human PD-L1 and binding human CD137. The invention furthermore relates to uses of the antibodies of the invention and to methods, nucleic acid constructs and host cells for producing antibodies of the invention.
Public/Granted literature
- US10968280B2 Binding agents binding to PD-L1 and CD137 and use thereof Public/Granted day:2021-04-06
Information query
